Years of slow progress and the unrelenting speed of ALS inspired Dan Doctoroff to found Target ALS and develop a revolutionary new model for research. Our approach is rapidly advancing the pace of science, breaking down barriers to progress, and fostering collaboration to enable discovery. Through the research we fund, enable, and conduct, we are fast-tracking breakthroughs and uniting academia, pharma and biotech, venture capital, government, other ALS nonprofits, and the ALS community. Our game-changing model transforms how ALS research happens — and the impact is clear. More than 750 research grants funded. Over $80 million invested in research at every level. 14 clinical trials launched to move closer to treatments. Hundreds of participants worldwide enrolled in our ALS Global Research Initiative, the most inclusive ALS study ever. We’re not waiting for change, we’re making it — and you can help. Add your name to join our movement and learn more about our efforts to create a world where everyone with ALS lives.